6 completed. 6 Phase 1, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 6 | Completed 6 |
| Phase 2 | 4 | Completed 4 |
Follow Cysteamine: new trials by email Literature Review of Cysteamine trials Research Report on Cysteamine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PK and PD Study of NPI-001 and Cysteamine Bitartrate Cysteamine Bitartrate, N-Acetylcysteine Amide - Cystinosis | Phase 1 / Phase 2 | Completed | Nacuity Pharmaceuticals, Inc. | 8 | 2023-10-29 | 2026-10-13 |
| Cysteamine for Asthma Cysteamine Bitartrate, Placebo Oral Tablet - Asthma | Phase 1 | Completed | Children's Hospital Medical Center, Cincinnati | 60 | 2019-06-18 | 2021-05-06 |
| First Study of Oral Cysteamine in Cystic Fibrosis Cysteamine - Cystic Fibrosis | Phase 1 / Phase 2 | Completed | University of Aberdeen | 10 | 2014-08-01 | 2015-11-05 |
| Pilot Study of Safety, Tolerability, Pharmacokinetics/Pharmacodynamics of RP103 Compared to Cystagon® in Patients With Cystinosis Cystagon®, RP103 - Cystinosis | Phase 1 / Phase 2 | Completed | Amgen | 9 | 2009-05-01 | 2024-12-19 |
| A Preliminary Study to Evaluate Cysteamine Therapy in Human Subjects With Non-Alcoholic Steatohepatitis (NASH) Cysteamine - Fatty Liver | Phase 1 / Phase 2 | Completed | Joel Lavine | 13 | 2008-10-01 | 2014-01-31 |
| New Cysteamine Eye Drops Formulation to Treat Corneal Crystals in Cystinosis Cysteamine - Cystinosis | Phase 1 | Completed | National Eye Institute (NEI) | 51 | 1998-05-01 | 2008-03-04 |
Cystinosis (3) · Asthma (1) · Cystic Fibrosis (1) · Fatty Liver (1) · Non-alcoholic Fatty Liver Disease (1) · Rare Diseases (1)
Amgen (1) · Children's Hospital Medical Center, Cincinnati (1) · Joel Lavine (1) · Nacuity Pharmaceuticals, Inc. (1) · National Eye Institute (NEI) (1) · University of Aberdeen (1)
United States (4) · Australia (1) · United Kingdom (1)
Graham Devereux, MD (1) · Gurjit K Khurana Hershey, MD, PhD (1) · Hugh McCarthy, PhD, FRACP (1)
2014 (1)